165 related articles for article (PubMed ID: 18544336)
1. Pilosulin 5, a novel histamine-releasing peptide of the Australian ant, Myrmecia pilosula (Jack Jumper Ant).
Inagaki H; Akagi M; Imai HT; Taylor RW; Wiese MD; Davies NW; Kubo T
Arch Biochem Biophys; 2008 Sep; 477(2):411-6. PubMed ID: 18544336
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia.
Inagaki H; Akagi M; Imai HT; Taylor RW; Kubo T
Arch Biochem Biophys; 2004 Aug; 428(2):170-8. PubMed ID: 15246874
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of major peptides in 'jack jumper' ant venom by mass spectrometry.
Davies NW; Wiese MD; Brown SG
Toxicon; 2004 Feb; 43(2):173-83. PubMed ID: 15019477
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of Myrmecia pilosula (jack jumper) ant venom.
Wiese MD; Chataway TK; Davies NW; Milne RW; Brown SG; Gai WP; Heddle RJ
Toxicon; 2006 Feb; 47(2):208-17. PubMed ID: 16376960
[TBL] [Abstract][Full Text] [Related]
5. Pilosulins: a review of the structure and mode of action of venom peptides from an Australian ant Myrmecia pilosula.
Wanandy T; Gueven N; Davies NW; Brown SG; Wiese MD
Toxicon; 2015 May; 98():54-61. PubMed ID: 25725257
[TBL] [Abstract][Full Text] [Related]
6. Myrmecia pilosula (Jack Jumper) ant venom: identification of allergens and revised nomenclature.
Wiese MD; Brown SG; Chataway TK; Davies NW; Milne RW; Aulfrey SJ; Heddle RJ
Allergy; 2007 Apr; 62(4):437-43. PubMed ID: 17362256
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula.
Wu QX; King MA; Donovan GR; Alewood D; Alewood P; Sawyer WH; Baldo BA
Biochim Biophys Acta; 1998 Sep; 1425(1):74-80. PubMed ID: 9813247
[TBL] [Abstract][Full Text] [Related]
8. Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.
Zelezetsky I; Pag U; Antcheva N; Sahl HG; Tossi A
Arch Biochem Biophys; 2005 Feb; 434(2):358-64. PubMed ID: 15639237
[TBL] [Abstract][Full Text] [Related]
9. Stability of Myrmecia pilosula (Jack Jumper) Ant venom for use in immunotherapy.
Wiese MD; Davies NW; Chataway TK; Milne RW; Brown SG; Heddle RJ
J Pharm Biomed Anal; 2011 Jan; 54(2):303-10. PubMed ID: 20869831
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of cell killing by the jumper ant venom peptide pilosulin 1.
King MA; Wu QX; Donovan GR; Baldo BA
Cytometry; 1998 Aug; 32(4):268-73. PubMed ID: 9701394
[TBL] [Abstract][Full Text] [Related]
11. Towards complete identification of allergens in Jack Jumper (Myrmecia pilosula) ant venom and their clinical relevance: An immunoproteomic approach.
Wanandy T; Wilson R; Gell D; Rose HE; Gueven N; Davies NW; Brown SGA; Wiese MD
Clin Exp Allergy; 2018 Sep; 48(9):1222-1234. PubMed ID: 29975807
[TBL] [Abstract][Full Text] [Related]
12. Identification of an IgE-binding determinant of the major allergen Myr p I from the venom of the Australian jumper ant Myrmecia pilosula.
Donovan GR; Street MD; Baldo BA; Alewood D; Alewood P; Sutherland S
Biochim Biophys Acta; 1994 Jan; 1204(1):48-52. PubMed ID: 7508264
[TBL] [Abstract][Full Text] [Related]
13. Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components.
Tani N; Kazuma K; Ohtsuka Y; Shigeri Y; Masuko K; Konno K; Inagaki H
Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658410
[TBL] [Abstract][Full Text] [Related]
14. Myrmecia pilosula (Jack Jumper) ant venom: validation of a procedure to standardise an allergy vaccine.
Wiese MD; Milne RW; Davies NW; Chataway TK; Brown SG; Heddle RJ
J Pharm Biomed Anal; 2008 Jan; 46(1):58-65. PubMed ID: 17933477
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of the major allergen Myr p II from the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a common protein leader sequence.
Street MD; Donovan GR; Baldo BA
Biochim Biophys Acta; 1996 Feb; 1305(1-2):87-97. PubMed ID: 8605256
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and Radiosensitizing Potentials of Pilosulin-3, a Recombinant Ant Venom, in Breast Cancer Cells.
Alzeer RM; Al-Hadyan KS; Al-Harbi NM; Bin Judia SS; Almeer RS; Alsbeih GA
Toxins (Basel); 2023 Dec; 15(12):. PubMed ID: 38133205
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial-DNA sequence evidence on the phylogeny of Australian jack-jumper ants of the Myrmecia pilosula complex.
Crozier RH; Dobric N; Imai HT; Graur D; Cornuet JM; Taylor RW
Mol Phylogenet Evol; 1995 Mar; 4(1):20-30. PubMed ID: 7620633
[TBL] [Abstract][Full Text] [Related]
18. Some enzymic activities of two Australian ant venoms: a jumper ant Myrmecia pilosula and a bulldog ant Myrmecia pyriformis.
Matuszek MA; Hodgson WC; King RG; Sutherland SK
Toxicon; 1994 Dec; 32(12):1543-9. PubMed ID: 7725323
[TBL] [Abstract][Full Text] [Related]
19. Structure-based epitope prediction and assessment of cross-reactivity of Myrmecia pilosula venom-specific IgE and recombinant Sol g proteins (Solenopsis geminata).
Buraphaka H; Dobutr T; Wiese MD; Lopata AL; Daduang S
Sci Rep; 2024 May; 14(1):11145. PubMed ID: 38750087
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological studies of jumper ant (Myrmecia pilosula) venom: evidence for the presence of histamine, and haemolytic and eicosanoid-releasing factors.
Matuszek MA; Hodgson WC; Sutherland SK; King RG
Toxicon; 1992 Sep; 30(9):1081-91. PubMed ID: 1440645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
